Close Menu

NEW YORK (360Dx) – Beckman Coulter said today that it has received Medical Device License approval from Health Canada for its DxH 900 Hematology Analyzer and its Early Sepsis Indicator.

The two tools were designed to improve a laboratory or institution's ability to detect "critical, potentially life-threatening, blood conditions, and/or diseases like sepsis," Beckman Coulter, which is part of Danaher, said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.